GLP-1 TV · From the company · views checked Oct 2026
CoreAge Rx Review: From 291 Pounds to a New Me (Tirzepatide Journey)
From the company
Our summary
C.J. Snavely, who says they are from Enola, Pennsylvania, shares a personal weight loss story and says they have been a CoreAge Rx subscriber since the end of March 2026. According to the video, the starting weight was 291.2 lb, and the speaker reports being down 50.7 lb at the time of recording, later citing 51.1 lb.
From the company's own channel: its marketing, not an independent review.
CoreAge Rx today
Named in this video. The price is today's, read off the program's own site, all in per month; what a video says it paid can be months old.
Where Wegovy costs least today
The three cheapest partner programs for Wegovy, all in per month, checked weekly. Brand Wegovy and compounded versions are different products; each row says which it is.
What else the video covers
The speaker says they began Zepbound in March 2025, reached 7.5 mg, and lost 32.2 lb in the first few months. When insurance stopped covering it at the end of July 2025, they say their doctor recommended Wegovy. They report starting at 0.25 mg and working up to 2.4 mg over 8 months, but say appetite changes and food noise continued, the weight went up and down, and they lost only an additional 2.6 lb.
The speaker then describes returning to tirzepatide through CoreAge Rx. They say they were skeptical because of few reviews and paying before approval, chose the one-year plan as the most affordable, and paid in monthly installments through Affirm. They report that sign-up, approval, and shipping were quick, with medication arriving 3 days later, and that their doctor started them at 12.5 mg. They say they took the first dose on March 29th and are down 19.28 lb going into week eight. They also describe tightening their diet, adding supplements from 1st Phorm, and using the CoreAge community, nurse sessions, and dietitian sessions. The closing message is about progress over perfection and non-scale changes.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 1:04 The speaker says they started Zepbound in March 2025, reached 7.5 mg, and lost 32.2 lb in the first few months.
- 1:34 After insurance stopped covering Zepbound, the speaker says they spent 8 months on Wegovy, reaching 2.4 mg, and lost only 2.6 lb more.
- 2:05 The speaker explains why they chose CoreAge Rx's one-year plan, paying through Affirm, and says the medication arrived 3 days after approval.
- 2:36 They say they restarted tirzepatide at 12.5 mg and tightened their diet with a focus on protein, balanced meals, and hydration.
- 3:36 The speaker reports being down 19.28 lb since restarting tirzepatide on March 29th, and 51.1 lb overall.
- 7:11 The speaker advises tracking overall trends and non-scale changes rather than daily scale readings, and describes feeling more confident.
Key moments
Where the talk turns, found in the captions. Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Wegovy and tirzepatide
- Doses mentioned
- 7.5 mg and 12.5 mg
- Who is speaking
- The company's own channel
Questions this video answers
How much weight did C.J. Snavely lose on Zepbound?
According to the video, the speaker started Zepbound in March 2025 and worked up to 7.5 mg. They report losing 32.2 lb during the first few months.
What happened when the speaker switched from tirzepatide to Wegovy?
The speaker says their insurance stopped covering Zepbound at the end of July 2025, so they switched to Wegovy on their doctor's recommendation. They report going from 0.25 mg to 2.4 mg over 8 months, struggling with appetite and food noise, and losing only 2.6 lb more.
How did the speaker pay for CoreAge Rx tirzepatide?
The speaker says they chose the one-year plan because it was the most affordable overall and used Affirm to split it into monthly payments. They also say they paid before approval, which they found strange at first.
What dose of tirzepatide did the speaker restart on?
The speaker says that because of prior GLP-1 experience, their doctor started them at 12.5 mg. They report taking the first dose on March 29th.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
CoreAge Rx Reviews: 72-Year-Old Drops 25 Pounds in 6 Weeks on TirzepatideJerry Lasso, a 72-year-old retired insurance executive living in Orlando, Florida, shares a progress update after joining CoreAge Rx on April 10, 2026.
70 Pounds Down on Zepbound: The Truth After 2 MonthsIn this video from the Living Phase 2 channel, Mike says he has lost 70 pounds in 10 months by combining more activity with tirzepatide (Zepbound).
GLP-1 / Zepbound / Tirzepatide Journey | 6 Month update, the good and the bad!Luis Zayas, who says he is 32, marks six months on a GLP-1 medication that he started on November 3, 2025.
Can GLP-1s Stop Working? The Truth Might Surprise You. Weekly Weigh-InThis is a weekly Q&A episode from the DOWNSIZED channel, hosted by married couple Lorraine and Christopher Durham.
About CoreAge Rx
From the company, 158 subscribers. 12 of their videos are in GLP-1 TV, 3.8K views between them.
- CoreAge Rx Injection Guide - Semaglutide & Tirzepatide Step-by-Step
- CoreAge Rx | NAD+ & GLP-1: The Smarter Path to Sustainable Weight Loss
- CoreAge Rx Reviews - Your First Steps To Compounded GLP-1
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Retatrutide: up to 28.3% weight loss in trials, no FDA approval yet, and no legal way to buy it today
Retatrutide is Eli Lilly's experimental weekly injection that acts on three hormone receptors (GIP, GLP-1 and glucagon). In the phase 3 TRIUMPH-1 trial, people on the 12 mg dose lost 28.3% of their weight at 80 weeks by Lilly's efficacy measure (25.0% counting everyone randomized). It is not FDA-approved, has no price, and cannot legally be sold. Lilly plans to file with FDA in Q1 2027. Tirzepatide is the closest thing you can buy now, compounded from $85 a month on our board.
- Zepbound dosage chart: every tirzepatide dose, the escalation rule, what each rung lost in the trial, and what it costs
Zepbound has six doses, 2.5 to 15 mg, taken once a week. The label's rule is four weeks at 2.5 mg, then 2.5 mg steps with at least four weeks on each, to a maintenance dose of 5, 10 or 15 mg. In SURMOUNT-1 those three doses lost 15.0, 19.5 and 20.9 percent of body weight over 72 weeks. Direct from Lilly each rung has a price, $299 at 2.5 mg rising to $699 at 10 mg and above, so the chart below carries the dose, the rule, the trial result and the bill in one place, plus the vial and KwikPen concentrations for anyone measuring in units.
- Zepbound vs Wegovy: the two weight-loss brands, priced every way you can buy them
Zepbound is tirzepatide and Wegovy is semaglutide, and in the one trial that ran them head-to-head, tirzepatide's molecule lost 20.2% of body weight against 13.7% over 72 weeks. That settles which is stronger. What it does not settle is which you can afford: Zepbound self-pay runs $299 to $699 a month by dose, Wegovy's pen is $349 flat and its new tablet starts at $149, and with a commercial plan that covers either, both fall to $25.
Find more like it
Dose changeWeigh-in and resultsFood, protein and eatingFood noise and cravings
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.